FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107619326> ?p ?o ?g. }

• W2107619326 endingPage "219" @default.
• W2107619326 startingPage "213" @default.
• W2107619326 abstract "Blockade of the renin-angiotensin system (RAS) by combined angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor (AT(1)) antagonist treatment with reduced dietary sodium intake produces suppression of cardiac growth and regression of cardiac hypertrophy. The purpose of this study was to investigate whether cardiac growth suppression by combined RAS blockade under conditions of dietary sodium restriction is associated with cardiomyocyte atrophy and contractile dysfunction and whether this intervention modifies cardiomyocyte inotropic responsiveness to angiotensin II (Ang II).Rats were fed a high (4% w/w) or low (0.2% w/w) NaCl diet for six days. Both groups were then given a combined intraperitoneal injection of perindopril (6 mg/kg/day) and losartan (10 mg/kg/day) with maintained dietary treatment for another seven days. At the end of the treatment period, animals were anaesthetised and their hearts were removed and weighed. Left ventricular cardiomyocytes were isolated by enzymatic dissociation and cell dimensions were evaluated. A line scan camera and digital imaging technique were used to assess cardiomyocyte contraction and inotropic responses to exogenous Ang II (10 to 10(-8) M).Dietary treatment alone had no effect on body growth, whereas combined RAS blockade suppressed somatic growth in the low sodium (LS) group, compared with the high sodium (HS) group. This growth suppression in the LS group was also evident in the heart at the organ and cellular level. Studies of cardiomyocyte contraction showed that myocytes from the LS group exhibited contractile instability and depression of contractile performance. Compared with the HS group, myocytes from the LS group showed a significant reduction in maximum cell shortening (6.40+0.17 vs. 7.32+0.16% resting length, p<0.05), and maximum rate of shortening (3.85+0.14 vs. 4.29+0.11 cell length/ms, p<0.05). Myocytes of the HS group exhibited negative inotropic responses to Ang II at all concentrations tested, with a significant reduction in maximum cell shortening by 11 16% after 12 minutes peptide exposure (p<0.05 vs. non-treated control). In comparison, Ang II elicited both positive and negative responses in myocytes from the LS group, with a predominant negative inotropic effect.This study provides evidence that combined RAS blockade treatment under restricted sodium intake conditions can impair cardiomyocyte contractile function in association with cardiomyocyte growth suppression. Chronic RAS blockade qualitatively alters the intrinsic inotropic status and responsiveness of ventricular cardiomyocytes, and this shift is further modulated by dietary sodium intake conditions." @default.
• W2107619326 created "2016-06-24" @default.
• W2107619326 creator A5012918166 @default.
• W2107619326 creator A5028337556 @default.
• W2107619326 creator A5030557564 @default.
• W2107619326 date "2003-12-01" @default.
• W2107619326 modified "2023-10-04" @default.
• W2107619326 title "Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility" @default.
• W2107619326 cites W1972960984 @default.
• W2107619326 cites W1985629410 @default.
• W2107619326 cites W1995262353 @default.
• W2107619326 cites W2001696702 @default.
• W2107619326 cites W2011600718 @default.
• W2107619326 cites W2014899753 @default.
• W2107619326 cites W2018312583 @default.
• W2107619326 cites W2021696092 @default.
• W2107619326 cites W2027825362 @default.
• W2107619326 cites W2028820007 @default.
• W2107619326 cites W2032371746 @default.
• W2107619326 cites W2037962635 @default.
• W2107619326 cites W2044844096 @default.
• W2107619326 cites W2050175593 @default.
• W2107619326 cites W2057586088 @default.
• W2107619326 cites W2058755393 @default.
• W2107619326 cites W2073702371 @default.
• W2107619326 cites W2081236923 @default.
• W2107619326 cites W2082110280 @default.
• W2107619326 cites W2089985641 @default.
• W2107619326 cites W2090940942 @default.
• W2107619326 cites W2095316629 @default.
• W2107619326 cites W2096682768 @default.
• W2107619326 cites W2098668436 @default.
• W2107619326 cites W2101702094 @default.
• W2107619326 cites W2104542933 @default.
• W2107619326 cites W2110085349 @default.
• W2107619326 cites W2125797129 @default.
• W2107619326 cites W2127384556 @default.
• W2107619326 cites W2130194578 @default.
• W2107619326 cites W2131283725 @default.
• W2107619326 cites W2165652470 @default.
• W2107619326 cites W2169162350 @default.
• W2107619326 cites W2040977707 @default.
• W2107619326 doi "https://doi.org/10.3317/jraas.2003.035" @default.
• W2107619326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14689368" @default.
• W2107619326 hasPublicationYear "2003" @default.
• W2107619326 type Work @default.
• W2107619326 sameAs 2107619326 @default.
• W2107619326 citedByCount "5" @default.
• W2107619326 countsByYear W21076193262012 @default.
• W2107619326 countsByYear W21076193262015 @default.
• W2107619326 countsByYear W21076193262019 @default.
• W2107619326 crossrefType "journal-article" @default.
• W2107619326 hasAuthorship W2107619326A5012918166 @default.
• W2107619326 hasAuthorship W2107619326A5028337556 @default.
• W2107619326 hasAuthorship W2107619326A5030557564 @default.
• W2107619326 hasBestOaLocation W21076193261 @default.
• W2107619326 hasConcept C126322002 @default.
• W2107619326 hasConcept C134018914 @default.
• W2107619326 hasConcept C155710745 @default.
• W2107619326 hasConcept C163415756 @default.
• W2107619326 hasConcept C167414201 @default.
• W2107619326 hasConcept C170493617 @default.
• W2107619326 hasConcept C185592680 @default.
• W2107619326 hasConcept C198710026 @default.
• W2107619326 hasConcept C207200792 @default.
• W2107619326 hasConcept C27016395 @default.
• W2107619326 hasConcept C2780288358 @default.
• W2107619326 hasConcept C2908929049 @default.
• W2107619326 hasConcept C39133596 @default.
• W2107619326 hasConcept C71924100 @default.
• W2107619326 hasConcept C84393581 @default.
• W2107619326 hasConceptScore W2107619326C126322002 @default.
• W2107619326 hasConceptScore W2107619326C134018914 @default.
• W2107619326 hasConceptScore W2107619326C155710745 @default.
• W2107619326 hasConceptScore W2107619326C163415756 @default.
• W2107619326 hasConceptScore W2107619326C167414201 @default.
• W2107619326 hasConceptScore W2107619326C170493617 @default.
• W2107619326 hasConceptScore W2107619326C185592680 @default.
• W2107619326 hasConceptScore W2107619326C198710026 @default.
• W2107619326 hasConceptScore W2107619326C207200792 @default.
• W2107619326 hasConceptScore W2107619326C27016395 @default.
• W2107619326 hasConceptScore W2107619326C2780288358 @default.
• W2107619326 hasConceptScore W2107619326C2908929049 @default.
• W2107619326 hasConceptScore W2107619326C39133596 @default.
• W2107619326 hasConceptScore W2107619326C71924100 @default.
• W2107619326 hasConceptScore W2107619326C84393581 @default.
• W2107619326 hasIssue "4" @default.
• W2107619326 hasLocation W21076193261 @default.
• W2107619326 hasLocation W21076193262 @default.
• W2107619326 hasLocation W21076193263 @default.
• W2107619326 hasOpenAccess W2107619326 @default.
• W2107619326 hasPrimaryLocation W21076193261 @default.
• W2107619326 hasRelatedWork W1969123217 @default.
• W2107619326 hasRelatedWork W2016647631 @default.
• W2107619326 hasRelatedWork W2027470168 @default.
• W2107619326 hasRelatedWork W2038571733 @default.
• W2107619326 hasRelatedWork W2042660006 @default.
• W2107619326 hasRelatedWork W2126797993 @default.

• next